More on imvt

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-1.4% Growth)
- Ratings (7.0 Score)

Upcoming Events

- Earnings (11/9/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Immunovant (NQ:IMVT)
Delayed: 28.41 -0.69 (2.37%)
Prev. Close $29.10  
Open$28.93 
52 Wk High$ 
52 Wk Low$ 
Day High$28.93 
Day Low$28.14 
P/E N/A  
EPS$ 
Volume641,437 

Friends, Peers and Foes (?): ROIV (more...)

Oct 23, 2026 04:55 PM Form 4 Immunovant, Inc. For: Oct 21 Filed by: Stout Jay S
Oct 9, 2026 05:06 PM Form 4 Immunovant, Inc. For: Oct 07 Filed by: Stout Jay S
Oct 9, 2026 05:05 PM Form 4 Immunovant, Inc. For: Oct 07 Filed by: Van Tuyl Christopher
Oct 9, 2026 05:04 PM Form 4 Immunovant, Inc. For: Oct 07 Filed by: Gloria Melanie
Oct 5, 2026 07:42 PM Form 4 Immunovant, Inc. For: Oct 01 Filed by: Venker Eric
Sep 25, 2026 04:06 PM Form 4 Immunovant, Inc. For: Sep 23 Filed by: Van Tuyl Christopher
Sep 25, 2026 12:00 PM Oppenheimer sees a buying opportunity in this U.S. biotech name
Sep 24, 2026 06:44 AM H.C. Wainwright Reiterates Buy Rating on Immunovant (IMVT)
Sep 23, 2026 07:01 AM Immunovant halts CLE development after IMVT-1402 trial misses goal
Sep 23, 2026 07:00 AM Immunovant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus
View All Articles

Entities mentioned with imvt

View All Entities